Symptomatic Bradycardia in Covid-19 Hospitalized Patients: a Case Series

The novel human coronavirus (COVID-19) was first reported in Wuhan, China, and has become the fifth documented pandemic which has spread worldwide and is currently a global threat. (Yu et al., 2006) Arrhythmic events have become a part of cardiac manifestations related to Covid-19 infection that has been reported in multiple publications. (Xiong, Redwood, Prendergast, and Chen, 2020, Bansal, 2020, Ulhaq and Soraya, 2020) Bradycardia as a possible clinical feature in Covid-19 hospitalized patients is not well understood but studies suggest this condition to be due to multiple factors which include direct myocardial damage, inflammatory response, hypoxia, and down-regulation of ACE2.
Source: International Journal of Infectious Diseases - Category: Infectious Diseases Authors: Source Type: research